Sodium-glucose co-transporter-2 drugs: are we sure they are useful only in the treatment of diabetes?

The sodium-glucose co-transporter-2 (SGLT2) inhibitors are a new class of oral anti-diabetic drugs acting through the inhibition of renal reabsorbtion of glucose. Three important randomized clinical trial in diabetic patients receiving SGLT2 inhibitors (vs. placebo), demonstrated a significant reduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Vassiliki’ Coutsoumbas, Gloria, Zagnoni, Silvia, Corona, Giovanni, Di Pasquale, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904067/
https://www.ncbi.nlm.nih.gov/pubmed/33654470
http://dx.doi.org/10.1093/eurheartj/suaa138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904067/
https://www.ncbi.nlm.nih.gov/pubmed/33654470
http://dx.doi.org/10.1093/eurheartj/suaa138

Ejemplares similares